Yi-Hung Lin

发表

First-in-Asian double-blind randomized trial to assess the efficacy and safety of insulin sensitizer in nonalcoholic steatohepatitis patients

Ming‐Lung Yu, Shiu-Feng Huang, M. Yeh, 2021, Hepatology International.

Pretreatment Hepatitis B Viral Load Predicts Long-Term Hepatitis B Response After Anti-Hepatitis C Therapy in Hepatitis B/C Dual-Infected Patients

Ming‐Lung Yu, Po-Lin Kuo, M. Yeh, 2018, The Journal of infectious diseases.

Role of hepatitis D virus in persistent alanine aminotransferase abnormality among chronic hepatitis B patients treated with nucleotide/nucleoside analogues.

Ming‐Lung Yu, Kuan-Yu Chen, M. Yeh, 2020, Journal of the Formosan Medical Association = Taiwan yi zhi.

Amelioration of glucose intolerance through directly acting antiviral agents in chronic hepatitis C cirrhotic patients without overt diabetes

Ming‐Lung Yu, M. Yeh, Chung‐Feng Huang, 2022, The Kaohsiung journal of medical sciences.

Clusters of Circulating let-7 Family Tumor Suppressors Are Associated with Clinical Characteristics of Chronic Hepatitis C

Ming‐Lung Yu, M. Yeh, Chung‐Feng Huang, 2020, International journal of molecular sciences.

Serum Wisteria floribunda agglutinin‐positive Mac‐2‐binding protein expression predicts disease severity in nonalcoholic steatohepatitis patients

Ming‐Lung Yu, M. Yeh, Chung‐Feng Huang, 2021, The Kaohsiung journal of medical sciences.

Regorafenib for Taiwanese patients with unresectable hepatocellular carcinoma after sorafenib failure: Impact of alpha‐fetoprotein levels

Ming‐Lung Yu, Kuan-Yu Chen, S. Chuang, 2021, Cancer medicine.

A real‐world impact of cost‐effectiveness of pegylated interferon/ribavarin regimens on treatment‐naïve chronic hepatitis C patients in Taiwan

Ming‐Lung Yu, M. Yeh, Chung‐Feng Huang, 2017, The Kaohsiung journal of medical sciences.

Concordance of SVR12, SVR24 and SVR durability in Taiwanese chronic hepatitis C patients with direct-acting antivirals

Ming‐Lung Yu, M. Yeh, Chung‐Feng Huang, 2021, PloS one.

Role of hepatitis D virus infection in development of hepatocellular carcinoma among chronic hepatitis B patients treated with nucleotide/nucleoside analogues

Ming‐Lung Yu, Kuan-Yu Chen, M. Yeh, 2021, Scientific Reports.

Identification of groups with poor cost-effectiveness of peginterferon plus ribavirin for naïve hepatitis C patients with a real-world cohort and database

Ming‐Lung Yu, Kuan-Yu Chen, M. Yeh, 2017, Medicine.

Circulating Let-7 Family Members as Non-Invasive Biomarkers for Predicting Hepatocellular Carcinoma Risk after Antiviral Treatment among Chronic Hepatitis C Patients

Ming‐Lung Yu, M. Yeh, Chung‐Feng Huang, 2022, Cancers.

Cure or curd: Modification of lipid profiles and cardio‐cerebrovascular events after hepatitis C virus eradication

W. Lai, Ming‐Lung Yu, M. Yeh, 2020, The Kaohsiung journal of medical sciences.

The association between hepatitis C virus infection and renal function

Ming‐Lung Yu, H. Tu, M. Yeh, 2021, Journal of the Chinese Medical Association : JCMA.

Equal treatment efficacy of direct-acting antivirals in patients with chronic hepatitis C and hepatocellular carcinoma? A prospective cohort study

Ming‐Lung Yu, M. Yeh, Chung‐Feng Huang, 2019, BMJ Open.

The applicability of non-invasive methods for assessing liver fibrosis in hemodialysis patients with chronic hepatitis C

Shang-Jyh Hwang, Ming‐Lung Yu, S. Chen, 2020, PloS one.

Ribavirin facilitates early viral kinetics in chronic hepatitis C patients receiving daclatasvir/asunaprevir

Ming‐Lung Yu, Kuan-Yu Chen, M. Yeh, 2020, Journal of gastroenterology and hepatology.

Evolutionary seroepidemiology of viral hepatitis and the gap in hepatitis C care cascades among uraemic patients receiving haemodialysis in Taiwan—the Formosa‐Like Group

Shang-Jyh Hwang, Ming‐Lung Yu, S. Chen, 2021, Journal of viral hepatitis.

Reactivation of hepatitis B in patients of chronic hepatitis C with hepatitis B virus infection treated with direct acting antivirals

P. Kuo, Ming‐Lung Yu, Kuan-Yu Chen, 2017, Journal of gastroenterology and hepatology.

Title : Reactivation of hepatitis B in patients of chronic hepatitis C with hepatitis B virus infection treated with direct acting antivirals Short title : HBV reactivation in DAA therapy Authorship

P. Kuo, Ming‐Lung Yu, M. Yeh, 2017 .

Identification of treatment-experienced hepatitis C patients with poor cost-effectiveness of pegylated interferon plus ribavirin from a real-world cohort.

Ming‐Lung Yu, Kuan-Yu Chen, M. Yeh, 2018, Journal of the Formosan Medical Association = Taiwan yi zhi.

Baseline Circulating miR-125b Levels Predict a High FIB-4 Index Score in Chronic Hepatitis B Patients after Nucleos(t)ide Analog Treatment

Jyun-Yi Wu, Ming‐Lung Yu, Yo-Chia Chen, 2022, Biomedicines.

Establishment of an outreach, grouping healthcare system to achieve microelimination of HCV for uremic patients in haemodialysis centres (ERASE-C)

Shang-Jyh Hwang, Ming‐Lung Yu, Jer-Ming Chang, 2020, Gut.

Effects of Achieving SVR on Clinical Characteristics and Surgical Outcomes in Patients Who Developed Early-Stage HCV-Related Hepatocellular Carcinoma and Received Curative Resection: Preoperative versus Postoperative SVR

M. Yeh, Chung‐Feng Huang, Ching-I. Huang, 2022, Viruses.